Computational and Practical Aspects of Drug Repositioning
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2015/07/01
-
Indian UGC (journal)
-
Refrences14
-
Citations66
-
Tudor I. Oprea Translational Informatics Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.
-
John P. Overington European Molecular Biology Laboratory–European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Cite
Oprea, Tudor I., and John P. Overington. “Computational and Practical Aspects of Drug Repositioning”. ASSAY and Drug Development Technologies, vol. 13, no. 6, 2015, pp. 299-06, https://doi.org/10.1089/adt.2015.29011.tiodrrr.
Oprea, T. I., & Overington, J. P. (2015). Computational and Practical Aspects of Drug Repositioning. ASSAY and Drug Development Technologies, 13(6), 299-306. https://doi.org/10.1089/adt.2015.29011.tiodrrr
Oprea TI, Overington JP. Computational and Practical Aspects of Drug Repositioning. ASSAY and Drug Development Technologies. 2015;13(6):299-306.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Peptide therapeutics: current status and future directions
- Exploiting the enhanced permeability and retention effect for tumor targeting
- Natural products in drug discovery
- A new and rapid colorimetric determination of acetylcholinesterase activity
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| EuroQSAR 2002—Designing Drugs and Crop Protectants: Processes, Problems and Solutions | 2003 | |||
| Drug repurposing from an academic perspective | Drug Discovery Today: Therapeutic Strategies | 166 | 2011 | |
Preclinical Enantioselective Pharmacology of (R)‐ and (S)‐ Ketorolac | The Journal of Clinical Pharmacology |
| 22 | 1998 |
| Consensus-Based Evaluation of Clinical Significance and Management of Anticancer Drug Interactions | Clinical Therapeutics |
| 20 | 2011 |
| A quality alert and call for improved curation of public chemistry databases | Drug Discovery Today |
| 63 | 2011 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Evaluation of bromocriptine and plumbagin against the monogenean Rhabdosynochus viridisi: Computational drug repositioning and in vitro approaches | Experimental Parasitology |
| 2024 | |
The Importance of the Piperazine Ring for the Development of Trypanomicide Compounds | ChemistrySelect |
| 1 | 2023 |
| Magic bullets, magic shields, and antimicrobials in between | Pharmaceutical Science Advances | 1 | 2023 | |
| Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion | Cell Cycle |
| 3 | 2023 |
A drug repurposing screen for whipworms informed by comparative genomics | PLOS Neglected Tropical Diseases |
| 1 | 2023 |
Citations Analysis
The category
Science: Biology (General) 21
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled DrugCentral: online drug compendium and was published in 2016. The most recent citation comes from a 2024 study titled Evaluation of bromocriptine and plumbagin against the monogenean Rhabdosynochus viridisi: Computational drug repositioning and in vitro approaches. This article reached its peak citation in 2022, with 14 citations. It has been cited in 55 different journals, 27% of which are open access. Among related journals, the Expert Opinion on Drug Discovery cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.